Friday, September 20, 2019 11:38:54 AM
ALL LITTLE KNOWLEDGE IS A DANGEROU THING DRINK DEEP BUT TASTE NOT.....
KMBJN the errors and misundeerstandings in your post are too numerous to address. If Dr. Mills had actually demonstrated what he has claimed it would be front page news in every newspaper on the planet. Instead his "discoeries" are found in obscure Youtube videos.
You sound like a smart man. Just the way your write indicates that. But at the same time you are naieve about how science works. That's not a crime. what is a crime or should be is sucking money out of people who don't understand how sicence works. Mills has managed to do this since 1991. He's either a crack pot or a con man. If he's the latter, he depends on people with too much money and too little knowledge.
Trendliner
KMBJN the errors and misundeerstandings in your post are too numerous to address. If Dr. Mills had actually demonstrated what he has claimed it would be front page news in every newspaper on the planet. Instead his "discoeries" are found in obscure Youtube videos.
You sound like a smart man. Just the way your write indicates that. But at the same time you are naieve about how science works. That's not a crime. what is a crime or should be is sucking money out of people who don't understand how sicence works. Mills has managed to do this since 1991. He's either a crack pot or a con man. If he's the latter, he depends on people with too much money and too little knowledge.
Trendliner
Recent NNVC News
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2025 08:33:17 PM
